RIO DE JANEIRO (Reuters) – Brazilian health regulator Anvisa said on Friday that a COVID-19 vaccine developed by Oxford University and AstraZeneca Plc had applied for full regulatory approval.
The submission, the first of its kind in Brazil, was made by the federally funded Fiocruz Institute, which will manufacture the British vaccine locally. A spokeswoman for AstraZeneca confirmed the submission.
(This story refiles to delete extraneous letter and fix name of regulator, to Anvisa, in lead)
(Reporting by Gabriel Stargardter; Editing by Leslie Adler)
